Results for this period
Interim period (second quarter)2024年4月1日~2024年9月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
砂糖事業では、家庭用製品が低調だった一方、インバウンドや観光需要の回復、夏場の猛暑を追い風に業務用製品や飲料ユーザー向けの販売が好調に推移した。バイオ事業では、販売アイテムの集約などにより売上高が前年を下回った。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年4月1日~2024年9月30日 |
| Net Sales | ¥16,162 million (YoY +3.8%) |
| Operating profit | ¥1,422 million (YoY +160.1%) |
| Ordinary income | ¥1,505 million (YoY +26.8%) |
| Profit attributable to owners of the parent | ¥1,055 million (YoY +17.0%) |
| Net income per share | 38.53円 |
| Equity ratio | End of the current fiscal period 53.9 / End of previous period 49.8 |
| Total assets | ¥26,680 million |
| Net assets | ¥14,384 million |
| Cash flows from operating activities | ¥2,005 million |
| Cash flows from investing activities | ¥-372 million |
| Cash flows from financing activities | ¥-1,147 million |
| Cash and cash equivalents at end of period | ¥2,789 million |
| Full-year earnings forecast | Net Sales ¥30,800 million (YoY -2.4%) / Operating profit ¥1,700 million (YoY +13.7%) / Ordinary income ¥1,800 million (YoY -15.4%) / Profit attributable to owners of the parent ¥1,300 million (YoY -11.9%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥9 → ¥5 |
| Segment revenue | Sugar business ¥15,318 million (YoY +5.0%), Bio Business ¥838 million (YoY -13.1%), Other ¥67 million (YoY +1.1%) |
| Segment profit | Sugar business ¥1,897 million (YoY +106.3%), Bio Business ¥186 million (YoY -11.6%), Other ¥39 million (YoY +5.4%) |
| Depreciation and amortization | ¥284 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥21 million / Extraordinary loss None |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name None / Excluded Number of companies 0 / Company name None |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 35,000,000 |
| Treasury Shares at Period-End | 7,553,429 |
| Factors Behind Changes in Business Performance | 砂糖事業では、家庭用製品が低調だった一方、インバウンドや観光需要の回復、夏場の猛暑を追い風に業務用製品や飲料ユーザー向けの販売が好調に推移した。バイオ事業では、販売アイテムの集約などにより売上高が前年を下回った。 |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.砂糖事業では、インバウンドや観光需要の回復、猛暑を追い風に業務用製品や飲料ユーザー向けの販売が好調だった。一方、バイオ事業では販売アイテムの集約などにより売上高が前年を下回った。